Physician profile
Brian N Dishinger
NPI 1982727426
$3,148.34
in general payments reported to CMS, 2019-2025
15 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,725 · 2020: $636 · 2021: $27.75 · 2022: $22.15 · 2023: $371 · 2024: $148 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717 · Education: $20.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.72 |
| Education | $20.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,097.95 | 2019 | |
| W. L. Gore & Associates, INC. | $301.76 | 2019-2025 | Gore Synecor Preperitoneal Biomaterial |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $267.66 | 2019-2024 | Xifaxan |
| Intuitive Surgical, INC. | $246.99 | 2019-2024 | |
| Abbvie INC. | $235.70 | 2019-2024 | Rinvoq, Skyrizi |
| Takeda Pharmaceuticals U.S.A., INC. | $229.75 | 2023-2024 | Entyvio, Gattex |
| Ethicon US, LLC | $190.48 | 2019 | |
| Ucb, INC. | $136.77 | 2019-2020 | |
| Covidien LP | $111.62 | 2019-2020 | |
| Janssen Biotech, INC. | $88.15 | 2020-2023 | Simponi, Stelara, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $67.51 | 2022-2023 | Dupixent |
| Shionogi INC | $60.39 | 2019 | |
| Braintree Laboratories, INC. | $58.07 | 2019-2023 | Sutab, Suflave |
| Novo Nordisk INC | $33.78 | 2025 | |
| Baxter Healthcare | $21.76 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dishinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.